What development phase is CEFPIRAMIDE in?

CEFPIRAMIDE is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

CEFPIRAMIDE

FDA-approved approved Small molecule Quality 15/100

At a glance

Generic name	CEFPIRAMIDE
Drug class	cefpiramide
Target	Bacterial penicillin-binding protein
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved
First approval	1989

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

CEFPIRAMIDE CI brief — competitive landscape report
CEFPIRAMIDE updates RSS · CI watch RSS